New data published in the New England Journal of Medicine (NEJM) and featured at the European Society for Medical Oncology (ESMO) Congress 2021 highlights a promising new treatment for individuals with HER2-mutant non-small cell lung cancer (NSCLC).
Newswise: Latest News
International Clinical Trial Delivers Promising Results of HER2-Targeted Therapy for Non-Small Cell Lung Cancer
September 18, 2021By
Jury delivers $25.5 million ‘statement’ to Aetna to change its ways
November 11, 2018By
An Oklahoma jury has awarded $ 25.5 million to the family of a cancer patient denied coverage by Aetna, with jurors saying that the insurer acted “recklessly” and that the verdict was meant as a message for Aetna to change its ways.
Implantable device delivers drugs straight to the heart
June 11, 2018By
A refillable, implantable device, sits directly on the heart and delivers drugs and other therapies to treat the after-effects of a heart attack.
Latest Science News — ScienceDaily
